敷尔佳：在研产品重组Ⅲ型人源化胶原蛋白冻干纤维完成临床试验

Core Viewpoint - The company has completed clinical trials for its product "Recombinant Type III Humanized Collagen Freeze-Dried Fiber" and is now ready to submit registration application materials [1] Group 1 - The clinical trial summary report has been obtained, indicating successful completion of the trials [1] - The clinical application of the product focuses on improving skin condition through moisturizing and hydrating effects of the recombinant type III humanized collagen [1]